Patent · US Active

Heterocyclic antiviral compounds

US8158631B2 · kind B2 · utility

12Cited by

0References

15Claims

0Family size

Assignee

Roche Palo Alto LLC · US

Inventors

Elbert Chin · San Mateo, US
Javier de Vicente Fidalgo · Foster City, US
Jim Li · San Francisco, US
Alfred Lui · Sunnyvale, US
Kristen Lynn McCaleb · Daly City, US
Ryan Craig Schoenfeld · San Jose, US
Francisco Xavier Talamas · Livingston, US

Key dates

Filing date	Jun 24, 2010
Grant date	Apr 17, 2012
Priority date	—
Expiry date	Jun 24, 2030

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D285/16
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

Compounds having the formula I wherein R1, R2, R3, R4, and R5 are as defined herein are Hepatitis C virus NS5b polymerase inhibitors. Also disclosed are compositions and methods for treating an HCV infection and inhibiting HCV replication.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.